chr21:44524456:G>A Detail (hg19) (U2AF1)
Information
Genome
Assembly | Position |
---|---|
hg19 | chr21:44,524,456-44,524,456 |
hg38 | chr21:43,104,346-43,104,346 View the variant detail on this assembly version. |
HGVS
Type | Transcript | Protein |
---|---|---|
RefSeq | NM_006758.2:c.101C>T | NP_006749.1:p.Ser34Phe |
NM_001025203.1:c.101C>T | NP_001020374.1:p.Ser34Phe | |
Ensemble | ENST00000291552.9:c.101C>T | ENST00000291552.9:p.Ser34Phe |
Summary
MGeND
Clinical significance |
![]() |
Variant entry | 97 |
GWAS entry | |
Disease area statistics | Show details |
Frequency
JP | HGVD:[No Data.] |
ToMMo:[No Data.] | |
NCBN:[No Data.] | |
NCBN(Hondo):[No Data.] | |
NCBN(Ryukyu):[No Data.] | |
East asia | ExAC:<0.001 |
Prediction
ClinVar
Clinical Significance |
![]() |
Review star | ![]() |
Show details |
Disease area statistics
MGeND
Clinical significance | Last evaluated | Condition | Origin | Submission ID | Submitter | Institute | Citation | Comment | Image |
---|---|---|---|---|---|---|---|---|---|
![]() |
malignant neoplasm of rectum |
![]() |
MGS000041
(TMGS000094) |
Hitoshi Nakagama | National Cancer Center Japan | ||||
![]() |
ill-defined sites within the digestive system |
![]() |
MGS000041
(TMGS000094) |
Hitoshi Nakagama | National Cancer Center Japan | ||||
![]() |
bronchus or lung, unspecified |
![]() |
MGS000041
(TMGS000094) |
Hitoshi Nakagama | National Cancer Center Japan | ||||
![]() |
Acute myeloblastic leukaemia |
![]() |
MGS000005
(TMGS000006) |
Keizo Horibe | National Hospital Organization Nagoya Medical Center | ||||
![]() |
Myelodysplastic syndromes |
![]() |
MGS000005
(TMGS000006) |
Keizo Horibe | National Hospital Organization Nagoya Medical Center | ||||
![]() |
colon, unspecified |
![]() |
MGS000042
(TMGS000093) |
Hitoshi Nakagama | National Cancer Center Japan | ||||
![]() |
extrahepatic bile duct |
![]() |
MGS000042
(TMGS000093) |
Hitoshi Nakagama | National Cancer Center Japan | ||||
![]() |
body of pancreas |
![]() |
MGS000042
(TMGS000093) |
Hitoshi Nakagama | National Cancer Center Japan | ||||
![]() |
ill-defined sites within the digestive system |
![]() |
MGS000042
(TMGS000093) |
Hitoshi Nakagama | National Cancer Center Japan | ||||
![]() |
bronchus or lung, unspecified |
![]() |
MGS000042
(TMGS000093) |
Hitoshi Nakagama | National Cancer Center Japan |
ClinVar
Clinical significance | Last evaluated | Review status | Condition | Origin | Links |
---|---|---|---|---|---|
![]() |
2016-05-31 | no assertion criteria provided |
![]() |
Detail | |
![]() |
2016-05-31 | no assertion criteria provided | pancreatic adenocarcinoma |
![]() |
Detail |
![]() |
2016-05-31 | no assertion criteria provided | Squamous cell carcinoma of the head and neck |
![]() |
Detail |
![]() |
2016-05-31 | no assertion criteria provided | acute myeloid leukemia |
![]() |
Detail |
![]() |
2016-05-31 | no assertion criteria provided | lung adenocarcinoma |
![]() |
Detail |
![]() |
2016-05-31 | no assertion criteria provided | Neoplasm of uterine cervix |
![]() |
Detail |
![]() |
2016-05-31 | no assertion criteria provided | myelodysplastic syndrome |
![]() |
Detail |
![]() |
2016-05-31 | no assertion criteria provided | Malignant neoplasm of body of uterus |
![]() |
Detail |
![]() |
2016-05-31 | no assertion criteria provided | uterine carcinosarcoma |
![]() |
Detail |
CIViC
Disease | Drug | EL | ET | ED | CS | VO | TR | Pubmed | Links |
---|---|---|---|---|---|---|---|---|---|
acute myeloid leukemia | B |
![]() |
![]() |
Positive | Somatic | 3 | 23029227 | Detail | |
acute myeloid leukemia | B |
![]() |
![]() |
N/A | Somatic | 2 | 23029227 | Detail | |
myelodysplastic syndrome | B |
![]() |
![]() |
Poor Outcome | Somatic | 3 | 23861105 | Detail |
DisGeNET
Score | Disease name | Description | Source | Pubmed | Links |
---|---|---|---|---|---|
<0.001 | de novo myelodysplastic syndromes | We previously identified missense mutations in the U2AF1 splicing factor affecti... | BeFree | 25311244 | Detail |
<0.001 | Miller Dieker syndrome | We previously identified missense mutations in the U2AF1 splicing factor affecti... | BeFree | 25311244 | Detail |
<0.001 | de novo myelodysplastic syndromes | We previously identified missense mutations in the U2AF1 splicing factor affecti... | BeFree | 25311244 | Detail |
<0.001 | Miller Dieker syndrome | These data suggest that the S34F mutation alters U2AF1 function in the context o... | BeFree | 25311244 | Detail |
Annotation
Annotations
Descrption | Source | Links |
---|---|---|
Age, sex, FAB subtype and karyotypes were not statistically significant between AML patients with U2... | CIViC Evidence | Detail |
In patients with AML, complete remission rates are not different between patients who harbor the U2A... | CIViC Evidence | Detail |
After adjusting for age and cancer stage, the presence of U2AF mutations such as S34Y/F are prognost... | CIViC Evidence | Detail |
NM_006758.3(U2AF1):c.101C>T (p.Ser34Phe) AND Transitional cell carcinoma of the bladder | ClinVar | Detail |
NM_006758.3(U2AF1):c.101C>T (p.Ser34Phe) AND Pancreatic adenocarcinoma | ClinVar | Detail |
NM_006758.3(U2AF1):c.101C>T (p.Ser34Phe) AND Squamous cell carcinoma of the head and neck | ClinVar | Detail |
NM_006758.3(U2AF1):c.101C>T (p.Ser34Phe) AND Acute myeloid leukemia | ClinVar | Detail |
NM_006758.3(U2AF1):c.101C>T (p.Ser34Phe) AND Lung adenocarcinoma | ClinVar | Detail |
NM_006758.3(U2AF1):c.101C>T (p.Ser34Phe) AND Neoplasm of uterine cervix | ClinVar | Detail |
NM_006758.3(U2AF1):c.101C>T (p.Ser34Phe) AND Myelodysplastic syndrome | ClinVar | Detail |
NM_006758.3(U2AF1):c.101C>T (p.Ser34Phe) AND Malignant neoplasm of body of uterus | ClinVar | Detail |
NM_006758.3(U2AF1):c.101C>T (p.Ser34Phe) AND Uterine carcinosarcoma | ClinVar | Detail |
We previously identified missense mutations in the U2AF1 splicing factor affecting codons S34 (S34F ... | DisGeNET | Detail |
We previously identified missense mutations in the U2AF1 splicing factor affecting codons S34 (S34F ... | DisGeNET | Detail |
We previously identified missense mutations in the U2AF1 splicing factor affecting codons S34 (S34F ... | DisGeNET | Detail |
These data suggest that the S34F mutation alters U2AF1 function in the context of specific RNA seque... | DisGeNET | Detail |
Overlapped Transcript Coordinates
Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
---|
Overlapped Transcript
Gene | Transcript ID | Chromosome | Start | Stop | Links |
---|
- Gene
- -
- dbSNP
- rs371769427 dbSNP
- Genome
- hg19
- Position
- chr21:44,524,456-44,524,456
- Variant Type
- snv
- Reference Allele
- G
- Alternative Allele
- A
- East Asian Chromosome Counts (ExAC)
- 8582
- East Asian Allele Counts (ExAC)
- 1
- East Asian Heterozygous Counts (ExAC)
- 1
- East Asian Homozygous Counts (ExAC)
- 0
- East Asian Allele Frequency (ExAC)
- 1.1652295502213937E-4
- Chromosome Counts in All Race (ExAC)
- 118678
- Allele Counts in All Race (ExAC)
- 5
- Heterozygous Counts in All Race (ExAC)
- 5
- Homozygous Counts in All Race (ExAC)
- 0
- Allele Frequency in All Race (ExAC)
- 4.213080773184584E-5
- Variant (CIViC) (CIViC Variant)
- S34Y/F
- Transcript 1 (CIViC Variant)
- ENST00000291552.4
- Variant URL (CIViC Variant)
- https://civic.genome.wustl.edu/links/variants/128
- Summary (CIViC Variant)
- U2AF1 S34Y/F has been shown to be a recurrent mutation in acute myeloid leukemia (AML), myelodysplastic syndromes (MDS) and lung adenocarcinomas. This mutation is the most commonly identified variant in MDS, occurs in the first zinc finger domain of U2AF1 and has been demonstrated to alter splicing. The impact of U2AF1 mutations on overall survival in MDS has been debated, however, patients with U2AF1 mutations were shown to be at an increased risk of transformation to secondary AML. The presence of this mutation was not associated with a specific prognostic outcome in AML when compared to U2AF1 wildtype patients.
Genome browser